entertainment -WSS

entertainment

author：entertainment 2025-10-01 17:57:26 - browse：7

Stock illustration of computer and medication — Adobe

Digital therapeutics company Click Therapeutics announced Wednesday it will acquire the assets of Better Therapeutics, developer of a software-based treatment for diabetes. Click, which did not disclose how much it is paying for the assets, hopes to adapt Better’s tech for use alongside GLP-1 medications.

Better Therapeutics announced in March that it was delisting from the Nasdaq stock exchange and shutting down operations as it sought strategic alternatives. The company had been, since last year, searching for ways to stay afloat as its cash reserves dwindled.

Last, year, Better received Food and Drug Administration clearance for AspyreRx, a prescription app that delivers cognitive behavioral therapy and had been shown to reduce A1c levels in people with type 2 diabetes. Still, the company has been unable to ramp up significant commercial traction. Better also had a pipeline of other products targeting cardiometabolic conditions, and had made early claims about the benefits of AspyreRx in people taking GLP-1s for diabetes management.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

explore

WSS

The story of mRNA: From a loose idea to a tool that may help curb Covid

In areas with more Black doctors, Black people live longer

WATCH: Why do fingernails fall off when they're damaged?

WATCH: Why do fingernails fall off when they're damaged?

The science behind Janet Jackson's pregnancy at 49

Why drug prescriptions should include diagnoses

hotspot

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

knowledge

BioMarin wins approval for gene therapy to treat hemophilia A

Divers poised to search for children washed away in Pennsylvania flash flood

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Senate committee advances SCOTUS ethics bill after alleged justice misconduct

In age of alternative facts, a scholarly course on calling out crap

Vir antibody drug aimed at influenza A fails in clinical trial

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Wife of Gilgo Beach murder suspect files for divorce, court filing shows

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Tocagen's brain cancer gene therapy trial continues. Investors worry

knowledge

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

Judge rejects Trump's request to move Stormy Daniels hush

EF3 tornado rips through North Carolina amid extreme weather nationwide

7 more heat

Stanford president's case begs question: Who takes blame?

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

explore

leisure time

focus

knowledge